中(zhong)药(yao)饮(yin)(yin)片是(shi)中(zhong)药(yao)材经过(guo)按中(zhong)医药(yao)理论、中(zhong)药(yao)炮制方法，经过(guo)加工炮制后(hou)的(de)(de)(de)，可直接用于中(zhong)医临床的(de)(de)(de)中(zhong)药(yao)。近(jin)年(nian)(nian)来(lai)，在国(guo)家(jia)一(yi)系列利好(hao)政(zheng)策的(de)(de)(de)支持(chi)以及(ji)相(xiang)关(guan)监管部门(men)的(de)(de)(de)严格监管下(xia)，中(zhong)药(yao)饮(yin)(yin)片产业发展(zhan)迅速，饮(yin)(yin)片质(zhi)量不断提(ti)升同时，也推动了市(shi)(shi)场规(gui)模的(de)(de)(de)进(jin)一(yi)步增长。根据(ju)相(xiang)关(guan)数据(ju)显(xian)示，2020年(nian)(nian)我国(guo)中(zhong)药(yao)饮(yin)(yin)片市(shi)(shi)场规(gui)模已(yi)达到2400亿(yi)(yi)元(yuan)，预(yu)计2022年(nian)(nian)这(zhei)一(yi)规(gui)模将突(tu)破2600亿(yi)(yi)元(yuan)。

上周，国(guo)家(jia)药(yao)典委(wei)员会对今年(nian)(nian)首批(pi)50个中(zhong)(zhong)(zhong)药(yao)配(pei)方(fang)(fang)颗(ke)粒(li)国(guo)家(jia)药(yao)品标(biao)准进行公示。与(yu)此同时，政策层面也在为中(zhong)(zhong)(zhong)药(yao)配(pei)方(fang)(fang)颗(ke)粒(li)纳入集采“铺路”。到(dao)(dao)2020年(nian)(nian)，中(zhong)(zhong)(zhong)药(yao)配(pei)方(fang)(fang)颗(ke)粒(li)行业主营收(shou)入已经达到(dao)(dao)约(yue)255亿元。北京中(zhong)(zhong)(zhong)医药(yao)大学国(guo)家(jia)中(zhong)(zhong)(zhong)医药(yao)发(fa)展与(yu)战略研(yan)究院研(yan)究员邓勇认(ren)为，从中(zhong)(zhong)(zhong)药(yao)饮片到(dao)(dao)中(zhong)(zhong)(zhong)药(yao)配(pei)方(fang)(fang)颗(ke)粒(li)，中(zhong)(zhong)(zhong)药(yao)在更广范(fan)围内的集采，将成(cheng)为大势(shi)所(suo)趋。

中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)是我国(guo)传统(tong)(tong)医(yi)学(xue)的(de)(de)(de)(de)瑰(gui)宝，中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)与(yu)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)材、中(zhong)(zhong)(zhong)(zhong)(zhong)成(cheng)药(yao)(yao)(yao)成(cheng)为了中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)系统(tong)(tong)的(de)(de)(de)(de)3大(da)支柱(zhu)，是中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)临(lin)床(chuang)处方(fang)的(de)(de)(de)(de)重(zhong)要组成(cheng)部(bu)分，也是中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)药(yao)(yao)(yao)文(wen)化(hua)(hua)的(de)(de)(de)(de)重(zhong)要载(zai)体。随(sui)(sui)着中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)药(yao)(yao)(yao)现(xian)代化(hua)(hua)的(de)(de)(de)(de)发(fa)(fa)展(zhan)，中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)因其治疗(liao)慢性病、疑(yi)难杂症所具有(you)的(de)(de)(de)(de)明显(xian)优(you)势，被越(yue)来越(yue)多的(de)(de)(de)(de)患者接(jie)受和(he)认可。尤(you)其2020年以(yi)来，受新冠疫情(qing)(qing)影响(xiang)，中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)药(yao)(yao)(yao)受到了更加(jia)广泛的(de)(de)(de)(de)关注。数据显(xian)示(shi)，2019年我国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)市(shi)场规(gui)模已达到1932.5亿元。在疫情(qing)(qing)期间，我国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)出(chu)厂价格(ge)指(zhi)数持续增长，2020年第(di)一季度(du)增幅达到1.4%。随(sui)(sui)着中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)产业(ye)化(hua)(hua)和(he)市(shi)场化(hua)(hua)的(de)(de)(de)(de)不断扩大(da)和(he)升(sheng)级(ji)，加(jia)强(qiang)饮(yin)片(pian)(pian)管理(li)、保证质量和(he)安全，对于维护公众(zhong)健(jian)康(kang)(kang)、促进(jin)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)产业(ye)健(jian)康(kang)(kang)发(fa)(fa)展(zhan)、推动中(zhong)(zhong)(zhong)(zhong)(zhong)医(yi)药(yao)(yao)(yao)事业(ye)繁荣壮(zhuang)大(da)具有(you)重(zhong)要意义(yi)。本文(wen)在厘(li)清中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)的(de)(de)(de)(de)概念基础上(shang)，结合针对中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)开展(zhan)的(de)(de)(de)(de)调查研究，剖析我国(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)的(de)(de)(de)(de)行(xing)业(ye)发(fa)(fa)展(zhan)现(xian)况和(he)面临(lin)的(de)(de)(de)(de)突出(chu)问题，进(jin)而提出(chu)促进(jin)中(zhong)(zhong)(zhong)(zhong)(zhong)药(yao)(yao)(yao)饮(yin)片(pian)(pian)产业(ye)健(jian)康(kang)(kang)发(fa)(fa)展(zhan)的(de)(de)(de)(de)意见建议。

继今年全国省(sheng)际(ji)中(zhong)(zhong)药(yao)(材)采(cai)(cai)购联(lian)盟首次联(lian)采(cai)(cai)后，中(zhong)(zhong)药(yao)饮(yin)片再次迎来集(ji)(ji)采(cai)(cai)。近期，山西省(sheng)药(yao)械集(ji)(ji)中(zhong)(zhong)竞价采(cai)(cai)购网发布通知(zhi)，组织省(sheng)内医疗机构(gou)开展中(zhong)(zhong)药(yao)饮(yin)片集(ji)(ji)中(zhong)(zhong)带量(liang)采(cai)(cai)购相关品(pin)种采(cai)(cai)购数据(ju)填(tian)报(bao)。宁(ning)夏、山东上周也发布通知(zhi)，开展部分中(zhong)(zhong)药(yao)饮(yin)片品(pin)种相关数据(ju)填(tian)报(bao)工(gong)作。作为药(yao)品(pin)不合格“重(zhong)灾区”，中(zhong)(zhong)药(yao)饮(yin)片一(yi)直行业集(ji)(ji)中(zhong)(zhong)度不高。北京(jing)中(zhong)(zhong)医药(yao)大学法律系教(jiao)授邓(deng)勇在接受新京(jing)报(bao)采(cai)(cai)访时表示(shi)，集(ji)(ji)采(cai)(cai)开展有助(zhu)于规范中(zhong)(zhong)药(yao)饮(yin)片质量(liang)，产业集(ji)(ji)中(zhong)(zhong)度也将得以提高。

“集采的推(tui)广，会逐步推(tui)进(jin)中药(yao)饮(yin)片(pian)质(zhi)(zhi)量(liang)标准(zhun)的建立与完善，压缩各渠(qu)道的利润空间(jian)，让(rang)利于民，达(da)到降低(di)最终(zhong)销(xiao)售价格的目(mu)的。”近日，多省发布中药(yao)饮(yin)片(pian)集采通知(zhi)，南京医科(ke)大(da)学(xue)中西医结合研究所(suo)常务副所(suo)长(zhang)、江苏省人(ren)(ren)民医院国家药(yao)物临床试验(yan)机构中医消化(hua)专业点魏睦新教授(shou)告诉人(ren)(ren)民日报健康客(ke)户端记者，集采对(dui)供货商的资(zi)质(zhi)(zhi)要优先审(shen)核(he)，确保供货商对(dui)饮(yin)片(pian)产品(pin)(pin)有全周(zhou)期系(xi)统管理(li)，可(ke)以追踪中药(yao)饮(yin)片(pian)质(zhi)(zhi)量(liang)，个别稀缺(que)品(pin)(pin)种例外。这样会使饮(yin)片(pian)加(jia)工销(xiao)售企业进(jin)行重新洗(xi)牌，推(tui)进(jin)产业良性发展。

近日，上海市(shi)发布《关于(yu)开(kai)展本市(shi)中(zhong)(zhong)药(yao)饮片(pian)全(quan)流(liu)程追(zhui)溯(su)临床应用试(shi)点工作的通知》，选(xuan)取(qu)了上海5家知名中(zhong)(zhong)医院(yuan)和8家药(yao)企作为(wei)试(shi)点，支持使用溯(su)源饮片(pian)，并鼓励优质(zhi)优价，提(ti)升中(zhong)(zhong)药(yao)饮片(pian)品质(zhi)。

为加强(qiang)我(wo)省(sheng)中药材产地趁(chen)鲜(xian)加工管理，省(sheng)药品监(jian)督管理局制定了(le)《吉林省(sheng)规范中药材产地趁(chen)鲜(xian)切(qie)制指(zhi)导意见》(试行)。现印发(fa)你(ni)们，请结合(he)实(shi)际(ji)贯(guan)彻实(shi)施。

近(jin)日，2022年国抽品(pin)种(zhong)(zhong)也慢慢的浮(fu)出水面，小编先(xian)做整(zheng)理，抛砖引(yin)玉(yu)，望各(ge)位(wei)同行参与讨论，一起避坑(keng)。2022年国抽饮片品(pin)种(zhong)(zhong)主(zhu)要为以下9个品(pin)种(zhong)(zhong)：紫草、菊花(hua)、大黄(huang)、片姜黄(huang)、川牛膝、海金沙、艾叶、茜(qian)草、桃(tao)仁。

为(wei)贯彻落实《药(yao)(yao)(yao)(yao)品(pin)(pin)管理法》和(he)《中(zhong)(zhong)医药(yao)(yao)(yao)(yao)法》的相关要求，进一步规范中(zhong)(zhong)药(yao)(yao)(yao)(yao)饮(yin)片(pian)生(sheng)产(chan)(chan)企业采购产(chan)(chan)地加工（趁(chen)鲜切(qie)制(zhi)）中(zhong)(zhong)药(yao)(yao)(yao)(yao)材(cai)的行为(wei)，山西省药(yao)(yao)(yao)(yao)监局近日召(zhao)开全省中(zhong)(zhong)药(yao)(yao)(yao)(yao)饮(yin)片(pian)生(sheng)产(chan)(chan)企业采购产(chan)(chan)地加工（趁(chen)鲜切(qie)制(zhi)）中(zhong)(zhong)药(yao)(yao)(yao)(yao)材(cai)工作视(shi)频会(hui)(hui)议(yi)(yi)，省局药(yao)(yao)(yao)(yao)品(pin)(pin)生(sheng)产(chan)(chan)监管处、药(yao)(yao)(yao)(yao)品(pin)(pin)注(zhu)册(ce)处和(he)省药(yao)(yao)(yao)(yao)品(pin)(pin)检查中(zhong)(zhong)心(xin)有关人员在主会(hui)(hui)场参加，省内10家(jia)产(chan)(chan)地加工企业和(he)24家(jia)中(zhong)(zhong)药(yao)(yao)(yao)(yao)饮(yin)片(pian)生(sheng)产(chan)(chan)企业同时在线参加会(hui)(hui)议(yi)(yi)。

为进一步提高中药饮(yin)(yin)(yin)片(pian)(pian)质(zhi)量安全性和有(you)效(xiao)性，佛山市(shi)创新推出中药饮(yin)(yin)(yin)片(pian)(pian)质(zhi)量追(zhui)(zhui)溯(su)小程序，率(lv)先(xian)在全省对中药饮(yin)(yin)(yin)片(pian)(pian)生产经营实施质(zhi)量追(zhui)(zhui)溯(su)，确(que)保(bao)中药饮(yin)(yin)(yin)片(pian)(pian)来源可(ke)查、去向可(ke)追(zhui)(zhui)。